Introduction
Cancer is a major public health problem in the world, which caused by the disorders of cell proliferation mechanism. According to the World Health Organization (WHO) statistics, an estimated 14.1 million new cancer cases and 8.2 million cancer-related deaths occurred in 2012, compared with 12.7 million and 7.6 million in 2008, respectively [1, 2] .Therefore, developing an efficiently and safety method to treatment the malignancies has become a hot pot in nowadays. Because of orientation, location, less dosage, efficacy, little toxicity advantages, molecular targeted therapy attracted more and more attention.
In recent years, there were many small molecule anticancer drugs had been reported [3] [4] [5] [6] [7] [8] [9] [10] [11] . Among them, many molecules contained the thiopyrano [4,3-d] pyrimidine scaffold (Fig.1) . Therefore, design and synthesis of thiopyrano [4,3-d] pyrimidine derivative as small molecule inhibitors played a great role in the study of anticancer drugs. molecule inhibitors. Compound 1 was synthesized from methyl dimethyl 3,3'-thiodipropionate through five steps. First, methyl dimethyl 3,3'-thiodipropionate 2 with NaH through intramolecular condensation to get methyl 4-oxotetrahydro-2H-thiopyran-3-carboxylate 3.Compound 3 was treated with urea and NaOEt in EtOH from rt. to 70 °C to give compound 4 as a white solid. Then 4 was chlorinated with POCl 3 at 105°C to yield compound 5.Substitution reaction of 5 with morpholine at room temperature to afford 6 and then through the Suzuki reaction furnish target compound 1.
Materials and methods
All melting points were obtained on a Büchi Melting Point B-540 apparatus (Büchi Labortechnik,Flawil, Switzerland) and were uncorrected. The IR spectra were recorded by means of the KBr pellet technique on a Bruker FTS 135 spectrometer. NMR spectra were performed using Bruker 400 MHz spectrometers (Bruker Bioscience, Billerica, MA, USA) with TMS as an internal standard. Mass spectra (MS) were taken in ESI mode on Agilent 1100 LC-MS (Agilent, Palo Alto, CA, USA).Elemental analysis was determined on a Carlo-Erba 1106 Elemental analysis instrument (Carlo Erba,Milan, Italy). All the materials were obtained from commercial suppliers and used without purification, unless otherwise specified. Yields were not optimized. TLC analysis was carried out on silica gel plates GF254 (Qindao Haiyang Chemical,China).
Synthesis of compounds
The structures and the synthetic route were shown in Scheme 1. 
Methyl 4-oxotetrahydro-2H-thiopyran-3-carboxylate (3).
To the mixture of NaH (60%, 8.19g, 0.205mol) and anhydrous THF (100 mL), a solution of dimethyl 3,3'-thiodipropionate (31.8 g, 0.154 mol) in anhydrous THF (40 mL) was added via a dropping funnel over 1 h (the dropping funnel was rinsed with 15 mL of THF) at room temperature under N 2 . After stirring for 2 h at r.t, the reaction was complete by TLC analysis (20%EtOAc in petroleum ether). The mixture was transferred to a beake， dilute hydrochloric acid was added slowly with stirring maintaining the temperature below 20 °C; the final pH was 6-7. The organic layer was separated, and the aqueous layer was extracted with CH 2 Cl 2 (3×50mL). The combined organic layers were washed with brine(3×50mL), then dried over Na 2 SO 4 , the filtrate was concentrated under reduced pressure to afford 3 as a yellow viscous oil (26.8g, 99.8%) and was used for next step without further purification.
ESI-MS m/z: [M + H] + 175.2 7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine-2,4-diol (4).
Finely cut sodium metal (16.2g, 0.704mol) was added into 300mL anhydrous ethanol at ice bath with stirring. After the sodium metal was completely consumed, urea (32.7g, 0.545mol) and methyl 4-oxotetrahydro-2H-thiopyran-3-carboxylate (31.3g, 0.180mol) was added to the solution. The mixture was heated and refluxed for 24 h, and the reaction was monitored by TLC. The reaction mixture was concentrated under reduced pressure and the residue was poured onto ice water , then adjusted the pH to 6-7 with acetic acid under ice bath , filtration, the filter cake was washed with ice-water, dried to obtain a white solid 
Conclusions
In conclusion, one novel thiopyrano [4,3-d] pyrimidine derivative compound 1 was synthesized from methyl dimethyl 3,3'-thiodipropionate through cyclization, chlorination, substitution with morpholine and coupling with 5-bromopyridin-2-amine through Suzuki reaction. The compound 1, an important intermediate of PI3K inhibitors, played an important role in the further design and synthesis of thiopyrano [4,3-d] pyrimidine derivatives anticancer drugs.
